Immatics NV (IMTX)
11.02
-0.26
(-2.30%)
USD |
NASDAQ |
May 31, 16:00
11.02
0.00 (0.00%)
After-Hours: 20:00
Immatics Revenue (Annual): 58.46M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 58.46M |
December 31, 2022 | 182.27M |
December 31, 2021 | 41.13M |
Date | Value |
---|---|
December 31, 2020 | 35.69M |
December 31, 2019 | 20.65M |
December 31, 2018 | 4.452M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
20.65M
Minimum
2019
182.27M
Maximum
2022
67.64M
Average
41.13M
Median
2021
Revenue (Annual) Benchmarks
MorphoSys AG | 257.96M |
Affimed NV | 8.959M |
InflaRx NV | 0.0683M |
BioNTech SE | 4.134B |
CureVac NV | 58.20M |